日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Latest News

Pharmaceutical enterprises making innovation faster and more relevant

By He Wei in Shanghai | China Daily | Updated: 2020-07-23 11:43
Share
Share - WeChat
Visitors at the exhibition area of French pharmaceutical giant Sanofi during the second China International Import Expo in Shanghai on Nov 10, 2019. [Photo/Xinhua]

Global pharmaceutical enterprises are looking to boost business operations in China in a bid to make innovation faster and more relevant to the market.

Business executives attribute the upbeat prospects in China to a thriving digital landscape, strong on-the-ground demand for innovation as well as government efforts to cut red tape and encourage technological breakthroughs.

In July, German science and technology conglomerate Merck opened its M Lab Collaboration Center in Shanghai-an in-house facility that fosters new drug development and offers customized solutions from services to training.

Albeit being the ninth such hub worldwide, the one-stop, technology and training center houses 13 labs and claims to be the biggest of its kind for Merck. It boasts four new functionalities including supporting food and beverage security-related inspections as well as environmental industries that are exclusive to the China market.

"The M Lab means faster turnaround, lowered costs as no travel out of China is needed, access to a vast network of biologics and bio-development experts within Merck and enhanced customer convenience," said Steve Vermant, managing director of Merck Life Science China.

For instance, in a dedicated research lab into proteins-the fundamental building block of life sciences-the company provides solutions from protein preparation and analysis to a number of relevant research tools. These stand to provide customers in China with hands-on training and support them on method optimization and application extension.

The existing global network of M Labs has reaped gains across the value chain during the ongoing COVID-19 pandemic, said Ian Carmichael, vice-president and head of bio processing at Merck Life Science China.

"Some of the candidates for drugs or vaccines have been able to accelerate to commercialization because of the work that was done between Merck and the customers in the past. We can go from labs to clinical trials," Carmichael said.

1 2 Next   >>|

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 麻豆久久久久 | 久久综合五月开心婷婷深深爱 | 在线精品亚洲欧美日韩国产 | 84pao视频强力打造免费视频 | 欧洲精品欧美精品 | 精品国产一区二区在线 | 亚洲一区二区免费看 | 欧美高清成人 | 99精品视频在线观看re | 天堂资源最新在线 | 91成人影院未满十八勿入 | 中文字幕 在线观看 | 色综合久久婷婷天天 | 夜夜撸天天操 | 日本三级一区二区 | 欧美精品 在线播放 | 欧美成人一区在线 | 三级在线观看视频 | 黄免费在线 | 亚洲精品福利你懂 | 日韩一区二区在线视频 | 亚洲精品福利 | 成年人网站在线免费观看 | 精品精品 | 久久精品re| 亚洲在线免费视频 | 大伊香蕉在线观看视频 wap | 一级理伦| 欧美色黄视频 | 亚洲精品1区 | 亚洲看片网 | 小视频你懂得 | 天天综合久久 | 成人精品网站在线观看 | 久久久一区二区 | 产真a观专区 | 久久99国产综合精品免费 | 四虎欧美在线观看免费 | 国产欧美精品亚洲桃花岛 | 超碰激情| 亚洲精品国产网红在线 |